Gabelli Funds LLC Has $24.12 Million Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Gabelli Funds LLC trimmed its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 0.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 348,536 shares of the company’s stock after selling 1,300 shares during the quarter. Gabelli Funds LLC’s holdings in Henry Schein were worth $24,119,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently modified their holdings of the company. Invesco Ltd. lifted its position in Henry Schein by 0.4% during the 4th quarter. Invesco Ltd. now owns 4,963,409 shares of the company’s stock worth $343,468,000 after buying an additional 17,552 shares in the last quarter. FMR LLC raised its stake in shares of Henry Schein by 6.6% in the fourth quarter. FMR LLC now owns 3,498,033 shares of the company’s stock worth $242,064,000 after acquiring an additional 217,143 shares during the last quarter. Geode Capital Management LLC lifted its position in shares of Henry Schein by 0.5% during the fourth quarter. Geode Capital Management LLC now owns 3,169,033 shares of the company’s stock worth $218,762,000 after purchasing an additional 14,876 shares in the last quarter. Lyrical Asset Management LP bought a new stake in shares of Henry Schein during the fourth quarter valued at approximately $126,655,000. Finally, Clarkston Capital Partners LLC increased its holdings in shares of Henry Schein by 24.8% in the fourth quarter. Clarkston Capital Partners LLC now owns 1,744,225 shares of the company’s stock valued at $120,700,000 after purchasing an additional 346,420 shares in the last quarter. Institutional investors and hedge funds own 96.62% of the company’s stock.

Insider Activity at Henry Schein

In related news, CEO Bradford C. Connett sold 4,036 shares of the business’s stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total value of $287,161.40. Following the sale, the chief executive officer now directly owns 62,688 shares of the company’s stock, valued at approximately $4,460,251.20. The trade was a 6.05 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Philip A. Laskawy sold 2,604 shares of the company’s stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total transaction of $184,988.16. Following the completion of the transaction, the director now directly owns 24,805 shares of the company’s stock, valued at approximately $1,762,147.20. The trade was a 9.50 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.14% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on HSIC shares. Jefferies Financial Group upped their price objective on Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a report on Thursday, January 23rd. StockNews.com raised Henry Schein from a “hold” rating to a “buy” rating in a research note on Wednesday, April 9th. Bank of America upgraded Henry Schein from an “underperform” rating to a “buy” rating and lifted their price objective for the stock from $69.00 to $84.00 in a research report on Monday, January 6th. Wells Fargo & Company initiated coverage on shares of Henry Schein in a research report on Friday, February 14th. They set an “equal weight” rating and a $80.00 target price on the stock. Finally, UBS Group lowered their price target on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a research report on Wednesday, February 26th. Five research analysts have rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $81.10.

Henry Schein Stock Down 2.0 %

Henry Schein stock opened at $64.28 on Wednesday. The firm has a market capitalization of $7.98 billion, a price-to-earnings ratio of 26.45, a PEG ratio of 2.13 and a beta of 0.84. The company’s 50 day simple moving average is $71.27 and its 200 day simple moving average is $72.13. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. Henry Schein, Inc. has a fifty-two week low of $60.49 and a fifty-two week high of $82.49.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). The firm had revenue of $3.19 billion during the quarter, compared to the consensus estimate of $3.25 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. Henry Schein’s quarterly revenue was up 5.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.66 EPS. As a group, sell-side analysts anticipate that Henry Schein, Inc. will post 4.74 EPS for the current year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.